Chylomicrons are the largest and least dense lipoproteins — roughly 83–92 percent triacylglycerol by mass, with the biggest particles visible under a light microscope. Built in the small intestine, they carry absorbed dietary fat through lymph to muscle and adipose tissue.
Lipid Class
Triglyceride-rich lipoprotein (ultra low-density)
Core Composition
Triglycerides 83–92%, phospholipids 6–12%, cholesterol 1–3%, protein 1–2%
They are triglyceride droplets in a phospholipid-and-protein skin; protein is only 1–2 percent of mass.
Size and density run inversely, and chylomicrons sit at the extreme of both — near 1,000 nm, the only lipoproteins visible by light microscopy.
ApoB-48 is specific to chylomicrons; hepatic VLDL and LDL instead carry ApoB-100.
Metabolism & Transport
Monoglycerides and fatty acids from digestion are re-esterified in the smooth ER and packaged with ApoB-48.
Secreted into lacteals — the lymphatic capillaries of intestinal villi — they reach blood through the lymphatic system, bypassing the portal vein and first-pass liver metabolism.
HDL lends ApoC-II and ApoE; ApoC-II is the crucial cofactor for lipoprotein lipase, whose hydrolysis of triglyceride lets fatty acids enter adipose, cardiac, and skeletal muscle.
After unloading, ApoC-II returns to HDL while ApoE stays; the liver recognizes ApoB-48 and ApoE on remnants and endocytoses them.
Physiological Role
They are the postprandial pipeline, moving meal-derived fatty acids to adipose storage and muscle oxidation within hours of eating.
A small cholesterol fraction rides along to the liver.
Between meals the liver takes over, exporting fat as VLDL, delipidated onward to IDL and LDL.
Interactions
HDL is the exchange partner; genes tune the flow — APOA5 loss causes chylomicronemia, APOC3 inhibition a treatment target.
Remnants can penetrate the tunica intima and become trapped in the subendothelial space, feeding atherosclerotic plaque.
Clinical Relevance
Familial chylomicronemia syndrome (type I) follows bi-allelic mutations in LPL, APOC2, APOA5, LMF1, or GPIHBP1, driving triglycerides above 10 mmol/L with risk of recurrent pancreatitis.
Its signs are eruptive xanthomas, lipaemia retinalis, hepatosplenomegaly, and abdominal pain; uncontrolled diabetes and alcohol use disorder cause secondary forms.
Premature atherosclerosis is not typical of the familial syndrome: intact chylomicrons are too large to enter the intima, though remnants can.
Treatment rests on a lifelong very low-fat diet; fibrates and omega-3 fatty acids are not efficacious, while apoC-III and ANGPTL3 inhibitors are in development.